10-QPeriod: Q3 FY2025

MICROCHIP TECHNOLOGY INC Quarterly Report for Q3 Ended Dec 31, 2024

Filed February 6, 2025For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) reported a significant decline in net sales for the three and nine months ended December 31, 2024, compared to the prior year, primarily due to adverse macroeconomic conditions, including slowing economic activity, increased business uncertainty, persistent inflation, and high interest rates. These factors led customers to reduce inventory levels and delay or cancel orders. Despite the revenue shortfall, the company is focused on operational efficiency and managing its manufacturing capacity, including the announced closure of its Tempe, Arizona wafer fabrication facility (Fab 2), expected to generate annual savings of approximately $90 million. The company's gross profit margin also saw a decrease, influenced by lower sales volume, unfavorable product and geographic mix, and increased unabsorbed capacity charges. However, research and development expenses as a percentage of net sales increased, reflecting continued investment in new products and technologies, a core component of Microchip's strategy. The company's balance sheet shows a decrease in cash and cash equivalents, and an increase in net long-term debt, reflecting financing activities including new note issuances. Investors should note the ongoing macroeconomic challenges impacting the semiconductor industry, which have led to reduced demand and increased inventory levels for customers. The company's ability to navigate these headwinds, manage its cost structure, and continue its strategic investments in innovation will be key to its future performance. The significant tax-related matters, including ongoing IRS and Malaysian IRB audits, represent potential financial risks that warrant close monitoring.

Financial Highlights

56 data points
Beta

Revenue

$1.03B

54.7% Gross Margin

Net Income

-$53.60M

-5.2% Net Margin

EPS (Diluted)

$-0.10

Total Assets

$15.63B

Cash & Equivalents

$586.00M

Free Cash Flow

$253.40M

Financial Statements
Beta
Revenue$1.03B
Cost of Revenue$464.60M
Gross Profit$561.40M
R&D Expenses$246.20M
SG&A Expenses$158.20M
Operating Expenses$530.50M
Operating Income$30.90M
Net Income-$53.60M
EPS (Basic)$-0.10
EPS (Diluted)$-0.10
Shares Outstanding (Basic)537.40M
Shares Outstanding (Diluted)537.40M

Key Highlights

  • 1Significant year-over-year decline in net sales for both the three-month and nine-month periods ended December 31, 2024, attributed to macroeconomic headwinds impacting customer demand and inventory levels.
  • 2Announced closure of the Tempe, Arizona wafer fabrication facility (Fab 2) expected to yield approximately $90 million in annual cash savings.
  • 3Decreased gross profit margin due to lower sales volume, unfavorable mix, and increased unabsorbed capacity charges.
  • 4Increased research and development expenses as a percentage of net sales, indicating continued strategic investment in innovation despite revenue challenges.
  • 5Net long-term debt increased, reflecting debt issuances, while cash and cash equivalents decreased.
  • 6Ongoing significant tax disputes with U.S. IRS and Malaysian IRB, representing a potential financial risk.
  • 7Distributor inventory days decreased to 37 days at December 31, 2024, from 41 days at March 31, 2024, but remain a factor impacting sales.

Frequently Asked Questions

The primary reasons for the decline in net sales are adverse macroeconomic conditions, including slowing economic activity, increasing business uncertainty, persistent inflation, and high interest rates. These factors have led customers to reduce their inventory levels, delay orders, or cancel existing backlog.

The closure of Fab 2 is expected to generate approximately $90 million in annual cash savings. However, due to the company's 'first-in, first-out' inventory accounting, income statement savings are not expected until the start of the June 2026 quarter. The closure is also intended to help moderate inventory levels.

Microchip is involved in significant tax disputes with the U.S. Internal Revenue Service (IRS) and the Malaysian Inland Revenue Board (IRB). The Malaysian IRB assessment, if upheld, could result in income taxes and penalties up to $410.0 million. The IRS disputes also relate to transfer pricing matters. The ultimate outcome of these disputes is uncertain and could have a material adverse impact on the company's financial position, results of operations, or cash flows.

As of December 31, 2024, Microchip had $6.79 billion in outstanding indebtedness. The company is managing its debt through various issuances and repayments. It anticipates using its Revolving Credit Facility and Commercial Paper program to refinance its maturing 4.250% 2025 Notes. Microchip believes its existing liquidity sources, combined with cash from operations, borrowings, and potential future financing, will be sufficient to meet its anticipated cash requirements for at least the next 12 months. However, potential interest rate increases upon refinancing fixed-rate debt with variable-rate debt and the impact of any credit rating downgrades are factors to monitor.